S193 Pill: blue, round, 6mm
Generic Name: eszopiclone
The pill with imprint S193 (Blue, Round, 6mm) has been identified as Lunesta 3 mg and is used for Insomnia. It belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics and is classified as CSA Schedule 4 (Some potential for abuse).
Images for S193





Lunesta
- Generic Name
- eszopiclone
- Imprint
- S193
- Strength
- 3 mg
- Color
- Blue
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Sunovion Pharmaceuticals Inc.
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
silicon dioxide,
croscarmellose sodium,
hypromellose 2910 (6 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
titanium dioxide,
triacetin,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
63402-0193 | Sunovion Pharmaceuticals Inc. |
00440-7702 | Liberty Pharmaceuticals (repackager) |
33358-0227 | CorePharma, LLC (repackager) |
49999-0737 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
52959-0852 | H.J. Harkins Company, Inc. (repackager) |
54569-5684 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
54868-5394 (Discontinued) | Physicians Total Care Inc. (repackager) |
55289-0014 | PDRX Pharmaceuticals Inc. (repackager) |
Related images for "S193"
More about Lunesta (eszopiclone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (342)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.